Compound concentration required to reduce the cell proliferation of human acute B-lymphoblastic leukemia CCRF-SB cells by 50%, using MTT method.

Basic Information

ID: ALA651475

Type: Functional

Description: Compound concentration required to reduce the cell proliferation of human acute B-lymphoblastic leukemia CCRF-SB cells by 50%, using MTT method.

Format: BAO_0000219

Organism: Homo sapiens

Cell type: CCRF-SB

Target: CCRF-SB(ALA614542)

Document: ALA1135654

Compound concentration required to reduce the cell proliferation of human acute B-lymphoblastic leukemia CCRF-SB cells by 50%, using MTT method.: 1

Associated Items: Associated Bioactivities Associated Compounds

Activity Charts

Bioactivity

Activity Types for Assay ALA651475

IC50

Total(3)

Parent Molecular Weight	ALogP	Polar Surface Area
296.28	2.28	2.28
197.19	2.29	2.29
254.25	2.25	2.25

Parent Molecular Weight

ALogP

Polar Surface Area

296.28

2.28

197.19

2.29

254.25

2.25

Compound concentration required to reduce the cell proliferation of human acute B-lymphoblastic leukemia CCRF-SB cells by 50%, using MTT method.

Basic Information

Activity Charts

Compound Summary